CEACAM5 and hepatocellular carcinoma: The most observed diagnosis was that of moderately differentiated HCC with 422 study subjects diagnosed (422/1075, 39.3%) and had the higher positive rates of AFP+CA19-9+CEA (13/27, 48%).